Clinical and angiographic profile in coronary artery disease: Hospital outcome with emphasis on the very elderly;Perfil clínico-angiográfico na doença arterial coronariana: Desfecho hospitalar com ênfase nos muito idosos

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 4, 2010, Pages 422-429

  Galon, Micheli Zanotti ^a   Meireles, George César Ximenes ^a   Kreimer, Sérgio ^a   Marchiori, Gilberto Guilherme Ajjar ^a   Favarato, Desidério ^b   De Almeida, João Aparecido Pimenta ^a   Capeline, Lorena Squassante ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aged; Coronary artery disease; Heart catheterization; Risk factors; Sickness impact profile

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; ORAL ANTIDIABETIC AGENT; TICLOPIDINE; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DYSLIPIDEMIA; FEMALE; HEART CATHETERIZATION; HEART DEATH; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; SEX DIFFERENCE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; VERY ELDERLY;

EID: 78650796778     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2010005000127     Document Type: Article

References (38)

1. Ministério da Saúde. Datasus. Morbidade e mortalidade no Brasil por doenças cardiovasculares. [acesso em 2007 dez 19]. Disponível em http://www.datasus.gov. br.
2. US Department of Health and Human Services. Advance report of final mortality statistics. Washington: Public Health Service; 1990.
3. US Department of Health and Human Services. National hospital discharge survey. Washington: Public Health Service; 1987.
4. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007;50(23):2264-74.
5. Alexander K P, Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH, et al. Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol. 2000;35(3):731-8.
6. Thompson RC, Holmes DR Jr, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. J Am Coll Cardiol. 1991;17(6):1245-50.
7. Wennberg DE, Makenka DJ, Sengupta A, Lucas FL, Vaitkus PT, Quinton H, et al. Percutaneous transluminal coronary angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group. Am Heart J. 1999;137(4 pt 1):639-45.
8. Keller NM, Feit F. Coronary artery disease in the geriatric population. Prog Cardiovasc Dis. 1996;38(5):407-18.
9. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2(8607):349-60.
10. Sokolyk S, Tresch D. Treatment of myocardial infarction in elderly patients. Compr Ther. 1994;20(10):537-44.
11. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008;117(2):261-95.
12. Silber S, Albertsson P, Aviles F F, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26(8):804-47.
13. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(7): e166-286.
14. Steg PG, Goldeberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90(4):358-63.
15. Caro JJ, Magliaccio-Walle K. for the CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. Am J Med. 1999;107(6):568-72.
16. Santos ES, Minuzzo L, Pereira M P, Castillo MT, Palacio MA, Ramos R F, et al. Registro de síndrome coronariana em um centro de emergências em cardiologia. Arq Bras Cardiol. 2006;87(5):597-602.
17. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized controlled trials. Br Med J. 2000;321(7253):73-7.
18. Bassand J P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598-660.
19. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey de Jr, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)
20. Nicolau JC, Timerman A, Piegas LS, Marin-Neto JA, Rassi A Jr. Guidelines for unstable angina and non-ST-segment elevation myocardial infarction of the Brazilian Society of Cardiology (II Edition, 2007). Arq Bras Cardiol. 2007;89(4): e89-e131.
21. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006;48(7):1319-25.
22. Dzavík V, Buller CE, Lamas GA, Rankin JM, Mancini GB, Cantor WJ, et al. TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation. 2006;114(23):2449-57.
23. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. (Occluded Artery Trial Investigators). Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23):2395-407.
24. Van de W F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with STsegment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24(1):28-66.
25. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23(23):1809-40.
26. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-74.
27. Spencer FA, Goldberg RJ, Frederick PD, Malmgren J, Becker RC, Gore JM. Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]). Am J Cardiol. 2001;88(2):107-11.
28. Pilote L, Miller D P, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med. 1996;335(16):1198- 205.
29. Sokolyk S, Tresch D. Treatment of myocardial infarction in elderly patients. Compr Ther. 1994;20(10):537-44.
30. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-9.
31. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115(10):1211-7.
32. Azmus AD, Gottschall C, Manica A, Manica J, Duro K, Frey M, et al. Effectiveness of acetylcysteine in prevention of contrast nephropathy. J Invasive Cardiol. 2005;17(2):80-4.
33. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C, et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol. 2003;91(9):1051-4.
34. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol. 2003;41(5):718-24.
35. Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27(5):1007-19.
36. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90(6):2645-57.
37. Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, et al. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or = 80 years old versus those < 80 years old. Am J Cardiol. 2003;92(4):443-6.
38. Cohen HA, Williams DO, Holmes DR Jr, Selzer F, Kip KE, Johnston JM, et al. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J. 2003;146(3):513-9.